Short bowel syndrome in children: Current and potential therapies

Pediatric Drugs

Volumn 14, Issue 3, 2012, Pages 179-188

  Uko, Victor ^a   Radhakrishnan, Kadakkal ^a   Alkhouri, Naim ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Fish oils; Glucagon like pePtide 2; Parenteral nutrition; Short bowel syndrome; Soya oil emulsion; Teduglutide

Indexed keywords

BILE ACID; CARBOHYDRATE; CEPHALOSPORIN; CITRULLINE; COLISTIN; COTRIMOXAZOLE; CYANOCOBALAMIN; EPIDERMAL GROWTH FACTOR; GLUCAGON LIKE PEPTIDE 2; GLUCOSE; GLUTAMINE; GROWTH HORMONE; HISTAMINE H2 RECEPTOR ANTAGONIST; INTRALIPID; LIPID EMULSION; METRONIDAZOLE; OCTREOTIDE; OMEGAVEN; OXYNTOMODULIN; PROTON PUMP INHIBITOR; RIFAXIMIN; SOMATOMEDIN; TEDUGLUTIDE; URSODEOXYCHOLIC ACID;

ABDOMINAL CRAMP; ALPHA TOCOPHEROL DEFICIENCY; BACTERIAL OVERGROWTH; BREAST MILK; CALCIUM DEFICIENCY; CALORIC INTAKE; CHILD; CHOLESTASIS; CLINICAL TRIAL (TOPIC); CYTOMEGALOVIRUS INFECTION; ENTERIC FEEDING; ESSENTIAL FATTY ACID DEFICIENCY; FLUID THERAPY; FOLIC ACID DEFICIENCY; FOOD ALLERGY; GALLSTONE; GASTROSCHISIS; HUMAN; HYPERGLYCEMIA; ILEUM; INTESTINE INFECTION; INTESTINE RESECTION; JEJUNUM; LIVER DISEASE; LYMPHOPROLIFERATIVE DISEASE; MAGNESIUM DEFICIENCY; MALABSORPTION; NECROTIZING ENTEROCOLITIS; NEPHROLITHIASIS; NUTRITIONAL DEFICIENCY; ORGAN TRANSPLANTATION; PARENTERAL NUTRITION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SELENIUM DEFICIENCY; SEPSIS; SHORT BOWEL SYNDROME; SMALL BOWEL BACTERIAL OVERGROWTH; SMALL INTESTINE RESECTION; SODIUM ABSORPTION; SODIUM URINE LEVEL; SUBSTITUTION THERAPY; TRANSPLANTATION; VITAMIN D DEFICIENCY; ZINC DEFICIENCY;

ADAPTATION, PHYSIOLOGICAL; GASTROINTESTINAL AGENTS; GLUCAGON-LIKE PEPTIDE 2; GLUCAGON-LIKE PEPTIDES; HUMANS; INTESTINE, SMALL; INTESTINES; MALABSORPTION SYNDROMES; NUTRITIONAL STATUS; PARENTERAL NUTRITION; PARENTERAL NUTRITION, TOTAL; PEPTIDES; SHORT BOWEL SYNDROME;

EID: 84859791081     PISSN: 11745878     EISSN: 11792019     Source Type: Journal    
DOI: 10.2165/11594880-000000000-00000     Document Type: Review

References (100)

1. OKeefe SJ, Buchman AL, Fishbein TM, et al. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol 2006 Jan; 4 (1): 6-10 (Pubitemid 43129518)
2. Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003 Apr; 124 (4): 1111-34 (Pubitemid 36389810)
3. Jeong SH, Lee HJ, Bae HJ, et al. Factors affecting postoperative dietary adaPtation in short bowel syndrome. Hepatogastroenterology 2009 Jul-Aug; 56 (93): 1049-52
4. Longshore SW, Wakeman D, McMellen M, et al. Bowel resection induced intestinal adaPtation: progress from bench to bedside. Minerva Pediatr 2009 Jun; 61 (3): 239-51
5. Williamson RC. Intestinal adaPtation (first of two parts): structural, functional and cytokinetic changes.NEngl J Med 1978 Jun 22; 298 (25): 1393-402 (Pubitemid 8358630)
6. Iqbal CW, Qandeel HG, Zheng Y, et al. Mechanisms of ileal adaPtation for glucose absorPtion after proximal-based small bowel resection. J Gastrointest Surg 2008 Nov; 12 (11): 1854-64; discussion 1864-5
7. Thompson JS, Ferguson DC. Effect of the distal remnant on ileal adaPtation. J Gastrointest Surg 2000 Jul-Aug; 4 (4): 430-4
8. Hofmann AF, Poley JR. Role of bile acid malabsorPtion in pathogenesis of diarrhea and steatorrhea in patients with ileal resection: I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology 1972; 62 (5): 918-34
9. Goulet O, Baglin-Gobet S, Talbotec C, et al. Outcome and long-term growth after extensive small bowel resection in the neonatal period: a survey of 87 children. Eur J Pediatr Surg 2005; 15 (2): 95-101 (Pubitemid 40834266)
10. Goulet OJ, RevillonY, Jan D, et al. Neonatal short bowel syndrome. J Pediatr 1991 Jul; 119 (1 Pt 1): 18-23
11. Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like pePtide 2 improves nutrient absorPtion and nutritional status in short-bowel patients with no colon. Gastroenterology 2001 Mar; 120 (4): 806-15 (Pubitemid 32193176)
12. Sigalet DL, Lam V, Boctor D. The assessment, and glucagon-like pePtide-2 modulation, of intestinal absorPtion and function. Semin Pediatr Surg 2010 Feb; 19 (1): 44-9
13. Vanderhoof JA, McCusker RH, Clark R, et al. Truncated and native insulinlike growth factor I enhance mucosal adaPtation after jejunoileal resection. Gastroenterology 1992 Jun; 102 (6): 1949-56
14. Liu CD, Rongione AJ, Shin MS, et al. Epidermal growth factor improves intestinal adaPtation during somatostatin administration in vivo. J Surg Res 1996 Jun; 63 (1): 163-8 (Pubitemid 26197725)
15. Bailly-Botuha C, Colomb V, Thioulouse E, et al. Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome. Pediatr Res 2009 May; 65 (5): 559-63
16. Modi BP, Langer M, Ching YA, et al. Improved survival in a multidisciplinary short bowel syndrome program. J Pediatr Surg 2008 Jan; 43 (1): 20-4
17. Dowling RH, Booth CC. Functional compensation after small-bowel resection in man: demonstration by direct measurement. Lancet 1966 Jul 16; 2 (7455): 146-7
18. Ekema G, Milianti S, Boroni G. Total parenteral nutrition in patients with short bowel syndrome. Minerva Pediatr 2009 Jun; 61 (3): 283-91
19. Vanderhoof JA, Young RJ. Enteral and parenteral nutrition in the care of patients with short-bowel syndrome. Best Pract Res Clin Gastroenterol 2003 Dec; 17 (6): 997-1015
20. Kocoshis SA. Medical management of pediatric intestinal failure. Semin Pediatr Surg 2010 Feb; 19 (1): 20-6
21. Freund HR. Abnormalities of liver function and hepatic damage associated with total parenteral nutrition. Nutrition 1991 Jan-Feb; 7 (1): 1-5; discussion 5-6
22. Beath SV, Gowen H, Puntis JW. Trends in paediatric home parenteral nutrition and implications for service development. Clin Nutr 2011 Aug; 30 (4): 499-502
23. Steiger E, HPEN Working Group. Consensus statements regarding oPtimal management of home parenteral nutrition (HPN) access. JPEN J Parenter Enteral Nutr 2006 Jan-Feb; 30 (1 Suppl.): S94-5 (Pubitemid 43099748)
24. Andorsky DJ, Lund DP, Lillehei CW, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 2001 Jul; 139 (1): 27-33 (Pubitemid 32613983)
25. Joly F, Dray X, Corcos O, et al. Tube feeding improves intestinal absorPtion in short bowel syndrome patients. Gastroenterology 2009 Mar; 136 (3): 824-31
26. Vanderhoof JA, Langnas AN. Short-bowel syndrome in children and adults. Gastroenterology 1997 Nov; 113 (5): 1767-78 (Pubitemid 27461267)
27. Olieman JF, Penning C, Ijsselstijn H, et al. Enteral nutrition in children with short-bowel syndrome: current evidence and recommendations for the clinician. J Am Diet Assoc 2010 Mar; 110 (3): 420-6
28. Mazon A, Solera E, Alentado N, et al. Frequent IgE sensitization to latex, cows milk, and egg in children with short bowel syndrome. Pediatr Allergy Immunol 2008 Mar; 19 (2): 180-3 (Pubitemid 351197284)
29. Ventura A, Pineschi A, Tasso M. Cows milk intolerance and abdominal surgery: a puzzling connection. Helv Paediatr Acta 1986 Mar; 41 (6): 487-94 (Pubitemid 17044949)
30. Cummins AG, Thompson FM. Effect of breast milk and weaning on epithelial growth of the small intestine in humans. Gut 2002 Nov; 51 (5): 748-54 (Pubitemid 35216868)
31. Ksiazyk J, Piena M, Kierkus J, et al. Hydrolyzed versus nonhydrolyzed protein diet in short bowel syndrome in children. J Pediatr Gastroenterol Nutr 2002 Nov; 35 (5): 615-8 (Pubitemid 35417730)
32. Vanderhoof JA, Young RJ. Hydrolyzed versus nonhydrolyzed protein diet in short bowel syndrome in children [letter]. J Pediatr Gastroenterol Nutr 2004 Jan; 38 (1): 107
33. Bines J, Francis D, Hill D. Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula. J Pediatr Gastroenterol Nutr 1998 Feb; 26 (2): 123-8 (Pubitemid 28078472)
34. Jeppesen PB, Mortensen PB. Colonic digestion and absorPtion of energy from carbohydrates and medium-chain fat in small bowel failure. JPEN J Parenter Enteral Nutr 1999 Sep-Oct; 23 (5 Suppl.): S101-5
35. Jeppesen PB, Mortensen PB. The influence of a preserved colon on the absorPtion of medium chain fat in patients with small bowel resection. Gut 1998 Oct; 43 (4): 478-83 (Pubitemid 28462031)
36. Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaPtation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997 Oct; 113 (4): 1074-81 (Pubitemid 27418959)
37. Szkudlarek J, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorPtion in short bowel patients: a randomised, double blind, crossover, placebo controlled study. Gut 2000 Aug; 47 (2): 199-205 (Pubitemid 30489762)
38. McMellen ME, Wakeman D, Longshore SW, et al. Growth factors: possible roles for clinical management of the short bowel syndrome. Semin Pediatr Surg 2010 Feb; 19 (1): 35-43
39. da Costa MA, Campos AC, Coelho JC, et al. Oral glutamine and the healing of colonic anastomoses in rats. JPEN J Parenter Enteral Nutr 2003 May-Jun; 27 (3): 182-5; discussion 185-6
40. Duggan C, Stark AR, Auestad N, et al. Glutamine supplementation in infants with gastrointestinal disease: a randomized, placebo-controlled pilot trial. Nutrition 2004 Sep; 20 (9): 752-6 (Pubitemid 39120031)
41. Albers MJ, Steyerberg EW, Hazebroek FW, et al. Glutamine supplementation of parenteral nutrition does not improve intestinal permeability, nitrogen balance, or outcome in newborns and infants undergoing digestivetract surgery: results from a double-blind, randomized, controlled trial. Ann Surg 2005 Apr; 241 (4): 599-606 (Pubitemid 40397307)
42. Grover Z, Tubman R, McGuire W. Glutamine supplementation for young infants with severe gastrointestinal disease. Cochrane Database Syst Rev 2007 Jan 24; (1): CD005947
43. Drucker DJ. Biological actions and therapeutic potential of the glucagon-like pePtides. Gastroenterology 2002 Feb; 122 (2): 531-44 (Pubitemid 34117003)
44. Martin GR, Wallace LE, Hartmann B, et al. Nutrient-stimulated GLP-2 release and cryPt cell proliferation in experimental short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2005 Mar; 288 (3): G431-8 (Pubitemid 40261740)
45. Xiao Q, Boushey RP, Drucker DJ, et al. Secretion of the intestinotropic hormone glucagon-like pePtide 2 is differentially regulated by nutrients in humans. Gastroenterology 1999 Jul; 117 (1): 99-105 (Pubitemid 29297625)
46. Jeppesen PB, Hartmann B, Thulesen J, et al. Elevated plasma glucagon-like pePtide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut 2000 Sep; 47 (3): 370-6
47. Jeppesen PB,GilroyR, PertkiewiczM, et al.Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut 2011 Jul; 60 (7): 902-14
48. Jeppesen PB, Sanguinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipePtidyl pePtidase IV resistant glucagon-like pePtide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 2005 Sep; 54 (9): 1224-31 (Pubitemid 41192479)
49. Haderslev KV, Jeppesen PB, Hartmann B, et al. Short-term administration of glucagon-like pePtide-2: effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon. Scand J Gastroenterol 2002 Apr; 37 (4): 392-8 (Pubitemid 34274321)
50. Ferrone M, Scolapio JS. Teduglutide for the treatment of short bowel syndrome. Ann Pharmacother 2006 Jun; 40 (6): 1105-9 (Pubitemid 43886968)
51. Tappenden KA. Emerging therapies for intestinal failure. Arch Surg 2010 Jun; 145 (6): 528-32
52. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009 Sep; 250 (3): 395-402
53. Diamond IR, Sterescu A, Pencharz PB, et al. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 2009 Feb; 48 (2): 209-15
54. Lee SI, Valim C, Johnston P, et al. Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res 2009 Dec; 66 (6): 698-703
55. De Meijer VE, Le HD, Meisel JA, et al. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr 2010 Feb; 50 (2): 212-8
56. Cheung HM, Lam HS, Tam YH, et al. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid. Clin Nutr 2009 Apr; 28 (2): 209-12
57. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutritionassociated liver disease in two infantswith short bowel syndrome using parenteral fish oil: implications for futuremanagement. Pediatrics 2006 Jul; 118 (1): e197-201 (Pubitemid 46071136)
58. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008 Mar; 121 (3): e678-86
59. Sondheimer JM, Cadnapaphornchai M, Sontag M, et al. Predicting the duration of dependence on parenteral nutrition after neonatal intestinal resection. J Pediatr 1998 Jan; 132 (1): 80-4 (Pubitemid 28082536)
60. Quiró s-Tejeira RE, Ament ME, Reyen L, et al. Long-term parenteral nutritional support and intestinal adaPtation in children with short bowel syndrome: a 25-year experience. J Pediatr 2004; 145 (2): 157-63 (Pubitemid 38993385)
61. Sondheimer JM, Asturias E, Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 1998 Aug; 27 (2): 131-7 (Pubitemid 28354942)
62. Teitelbaum DH, Tracy T. Parenteral nutrition-associated cholestasis. Semin Pediatr Surg 2001 May; 10 (2): 72-80 (Pubitemid 32422655)
63. Btaiche IF, Khalidi N. Parenteral nutrition-associated liver complications in children. Pharmacotherapy 2002 Feb; 22 (2): 188-211 (Pubitemid 34112881)
64. San Luis VA, Btaiche IF. Ursodiol in patients with parenteral nutritionassociated cholestasis. Ann Pharmacother 2007 Nov; 41 (11): 1867-72 (Pubitemid 350044350)
65. Kouti V, Papazoglou L, Flaskos J, et al. Ursodeoxycholic acid promotes intestinal adaPtation in a cat model of short bowel syndrome. Fundam Clin Pharmacol 2011 Dec; 25 (6): 734-42
66. Taylor SF, Sondheimer JM, Sokol RJ, et al. Noninfectious colitis associated with short gut syndrome in infants. J Pediatr 1991 Jul; 119 (1 Pt 1): 24-8
67. Vanderhoof JA, Young RJ, Murray N, et al. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr 1998 Aug; 27 (2): 155-60 (Pubitemid 28354946)
68. Dibaise JK, Young RJ, Vanderhoof JA. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol 2006 Jan; 4 (1): 11-20 (Pubitemid 43136462)
69. Kanamori Y, Hashizume K, Sugiyama M, et al. Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: a novel synbiotics therapy for intestinal failure. Dig Dis Sci 2001 Sep; 46 (9): 2010-6 (Pubitemid 32844171)
70. Kanamori Y, Sugiyama M, Hashizume K, et al. Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis. J Pediatr Surg 2004 Nov; 39 (11): 1686-92 (Pubitemid 39488000)
71. Kukkonen K, Savilahti E, Haahtela T, et al. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics 2008 Jul; 122 (1): 8-12
72. Rao S, Srinivasjois R, Patole S. Prebiotic supplementation in full-term neonates: a systematic review of randomized controlled trials. Arch Pediatr Adolesc Med 2009 Aug; 163 (8): 755-64
73. Srinivasjois R, Rao S, Patole S. Prebiotic supplementation of formula in preterm neonates: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr 2009 Jun; 28 (3): 237-42
74. Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 2004 Apr; 38 (4): 457-8
75. De Groote MA, Frank DN, Dowell E, et al. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005 Mar; 24 (3): 278-80 (Pubitemid 40365870)
76. Land MH, Rouster-Stevens K, Woods CR, et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005 Jan; 115 (1): 178-81 (Pubitemid 43046298)
77. Zein EF, Karaa S, Chemaly A, et al. Lactobacillus rhamnosus sePticemia in a diabetic patient associated with probiotic use: a case report. Ann Biol Clin (Paris) 2008 Mar-Apr; 66 (2): 195-8 (Pubitemid 351561039)
78. Barrat E, Michel C, Poupeau G, et al. Supplementation with galactooligosaccharides and inulin increases bacterial translocation in artificially reared newborn rats. Pediatr Res 2008 Jul; 64 (1): 34-9
79. Slobbe L, Doorduijn JK, Lugtenburg PJ, et al. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS One 2010 May 26; 5 (5): e10840
80. Mouw E, Chessman K, Lesher A, et al. Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome. J Pediatr Surg 2008 Jun; 43 (6): 1025-9 (Pubitemid 351814902)
81. Severijnen R, Bayat N, Bakker H, et al. Enteral drug absorPtion in patients with short small bowel: a review. Clin Pharmacokinet 2004; 43 (14): 951-62 (Pubitemid 39602012)
82. Nightingale JM, Walker ER, Farthing MJ, et al. Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther 1991 Aug; 5 (4): 405-12
83. Nehra V, Camilleri M, Burton D, et al. An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol 2001 May; 96 (5): 1494-8 (Pubitemid 32455080)
84. Fried M. Octreotide in the treatment of refractory diarrhea. Digestion 1999; 60 Suppl. 2: 42-6 (Pubitemid 29178660)
85. Davies BW, Abel G, Puntis JW, et al. Limited ileal resection in infancy: the long-term consequences. J Pediatr Surg 1999 Apr; 34 (4): 583-7 (Pubitemid 29183793)
86. Barksdale EM, Stanford A. The surgical management of short bowel syndrome. Curr Gastroenterol Rep 2002 Jun; 4 (3): 229-37
87. Vernon AH, Georgeson KE. Surgical oPtions for short bowel syndrome. Semin Pediatr Surg 2001 May; 10 (2): 91-8 (Pubitemid 32422657)
88. Bianchi A. Intestinal loop lengthening: a technique for increasing smallintestinal length. J Pediatr Surg 1980 Apr; 15 (2): 145-51 (Pubitemid 10110498)
89. Bonnard A, Staub G, Segura JF, et al. Evaluation of intestinal absorPtion after longitudinal intestinal lengthening for short bowel syndrome. J Pediatr Surg 2005 Oct; 40 (10): 1587-91 (Pubitemid 41530120)
90. Bianchi A. Longitudinal intestinal lengthening and tailoring: results in 20 children. J R Soc Med 1997 Aug; 90 (8): 429-32 (Pubitemid 27379413)
91. Kim HB, Fauza D, Garza J, et al. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg 2003 Mar; 38 (3): 425-9 (Pubitemid 36278705)
92. Javid PJ, Kim HB, Duggan CP, et al. Serial transverse enteroplasty is associated with successful short-term outcomes in infants with short bowel syndrome. J Pediatr Surg 2005 Jun; 40 (6): 1019-23; discussion 1023-4
93. Modi BP, Langer M, Duggan C, et al. Serial transverse enteroplasty for management of refractory D-lactic acidosis in short-bowel syndrome. J Pediatr Gastroenterol Nutr 2006 Sep; 43 (3): 395-7 (Pubitemid 44368200)
94. Reinshagen K, Kabs C, Wirth H, et al. Long-term outcome in patients with short bowel syndrome after longitudinal intestinal lengthening and tailoring. J Pediatr Gastroenterol Nutr 2008 Nov; 47 (5): 573-8
95. Fishbein TM. Intestinal transplantation. N Engl J Med 2009 Sep 3; 361 (10): 998-1008
96. Abu-Elmagd KM, Mazariegos G, Costa G, et al. Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks. Transplantation 2009 Oct 15; 88 (7): 926-34
97. Mazariegos GV. Intestinal transplantation: current outcomes and opportunities. Curr Opin Organ Transplant 2009 Oct; 14 (5): 515-21
98. Vianna RM, Mangus RS. Present prospects and future perspectives of intestinal and multivisceral transplantation. Curr Opin Clin Nutr Metab Care 2009 May; 12 (3): 281-6
99. Grikscheit TC, Siddique A, Ochoa ER, et al. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg 2004 Nov; 240 (5): 748-54 (Pubitemid 39425765)
100. GuPta A, Dixit A, Sales KM, et al. Tissue engineering of small intestine: current status. Biomacromolecules 2006 Oct; 7 (10): 2701-9 (Pubitemid 44615249)